In the tumor microenvironment, however, our understanding of how phosphorylated IDO1 influences immune signaling pathways is limited, and the response of other IDO1‐expressing cells, apart from pDCs, to their microenvironment remains to be studied. The gene discussed is IDO1; the disease is neoplasm.